[go: up one dir, main page]

AU2003303074A1 - Sphingolipid derivatives modified by polyethylene glycol and composition containing the same - Google Patents

Sphingolipid derivatives modified by polyethylene glycol and composition containing the same

Info

Publication number
AU2003303074A1
AU2003303074A1 AU2003303074A AU2003303074A AU2003303074A1 AU 2003303074 A1 AU2003303074 A1 AU 2003303074A1 AU 2003303074 A AU2003303074 A AU 2003303074A AU 2003303074 A AU2003303074 A AU 2003303074A AU 2003303074 A1 AU2003303074 A1 AU 2003303074A1
Authority
AU
Australia
Prior art keywords
same
polyethylene glycol
composition containing
derivatives modified
sphingolipid derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003303074A
Inventor
Jin Hee Choi
Jinwook Kim
Chang Seo Park
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Doosan Corp
Original Assignee
Doosan Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Doosan Corp filed Critical Doosan Corp
Publication of AU2003303074A1 publication Critical patent/AU2003303074A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/20Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a carbon atom of an acyclic unsaturated carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32Polymers modified by chemical after-treatment
    • C08G65/329Polymers modified by chemical after-treatment with organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6905Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
    • A61K47/6911Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a liposome
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003303074A 2002-12-13 2003-12-11 Sphingolipid derivatives modified by polyethylene glycol and composition containing the same Abandoned AU2003303074A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR10-2002-0079663 2002-12-13
KR1020020079663A KR20040051958A (en) 2002-12-13 2002-12-13 Sphingolipid derivatives modified by polyethylene glycol and composition containing the same
PCT/KR2003/002716 WO2004054963A1 (en) 2002-12-13 2003-12-11 Sphingolipid derivatives modified by polyethylene glycol and composition containing the same

Publications (1)

Publication Number Publication Date
AU2003303074A1 true AU2003303074A1 (en) 2004-07-09

Family

ID=32588789

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003303074A Abandoned AU2003303074A1 (en) 2002-12-13 2003-12-11 Sphingolipid derivatives modified by polyethylene glycol and composition containing the same

Country Status (3)

Country Link
KR (1) KR20040051958A (en)
AU (1) AU2003303074A1 (en)
WO (1) WO2004054963A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050051862A (en) * 2003-11-28 2005-06-02 주식회사 두산 Sphingolipid-peg derivatives and composition for skin external use containing the derivatives
KR100736145B1 (en) * 2004-06-01 2007-07-06 주식회사 두산 Monomethylpytosphingosine-polyethylene glycol and anticancer composition containing same
WO2006080589A1 (en) * 2004-12-21 2006-08-03 Doosan Corporation Sphingolipid-peg derivatives and composition for skin external use containing the derivatives
WO2009076598A1 (en) 2007-12-12 2009-06-18 Children's Hospital & Research Center At Oakland Use of unsaturated sphingosine compounds as chemotherapeutic agents for the treatment of cancer
US20090187060A1 (en) * 2008-01-22 2009-07-23 E-Z-Em, Inc. Method and Formulation for Neutralizing Toxic Chemicals and Materials
KR102423002B1 (en) * 2021-02-17 2022-07-21 주식회사 엘씨에스바이오텍 New ceramide, method for preparing the new ceramide and its use
CN119174825B (en) * 2024-09-23 2025-07-04 西南大学 Amphotericin B nano-composite based on sphingosine coupling polyethylene glycol carrier and preparation method and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5225212A (en) * 1989-10-20 1993-07-06 Liposome Technology, Inc. Microreservoir liposome composition and method
US5820873A (en) * 1994-09-30 1998-10-13 The University Of British Columbia Polyethylene glycol modified ceramide lipids and liposome uses thereof

Also Published As

Publication number Publication date
WO2004054963A1 (en) 2004-07-01
KR20040051958A (en) 2004-06-19

Similar Documents

Publication Publication Date Title
AU2003227480A1 (en) Modified polymers and compositions containing the same
IL166129A0 (en) Pyrrolotriazine derivatives and pharmaceutical compositions containing the same
AU2003275719A1 (en) Deodorant composition
IL162548A0 (en) 4-Oxoquinoline derivatives and pharmaceutical compositions containing the same
AU2003254898A1 (en) Fragrance composition
AU2002306269A1 (en) N-arylphenylacetamide derivatives and pharmaceutical composition containing the same
AU2003291103A1 (en) Pharmaceutical composition
AU2003275620A1 (en) Capsule type hardener and composition
AU2003296188A1 (en) Radiation-sensitive resin composition
AU2003284401A1 (en) Cosmetic composition
AU2002367625A1 (en) Radiation-sensitive resin composition
AU2003285288A1 (en) Composition
AU2003280797A1 (en) Shampoo composition
AU2003289440A1 (en) Nitrogen-containing heterocycic derivatives, medicinal compositions containing the same and medicinal use thereof
AU2003227263A1 (en) Phosphor and phosphor composition containing the same
AU2003302315A1 (en) Desulfurization and novel compositions for same
AU2003256805A1 (en) Compounds compositions and methods
AU2003250372A1 (en) Pharmaceutical composition
IL165775A0 (en) Novel quinuclidine derivatives and medicinal compositions containing the same
AU2002950744A0 (en) Composition
AU2003289187A1 (en) Perfluoroallyloxy compound and liquid-crystal composition containing the compound
AU2003276710A1 (en) Deodorant composition
AU2003235708A1 (en) Polytartrate composition
EP1400571A3 (en) Aerosol composition
EP1422263B8 (en) Resin composition

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase